药物治疗是减少冠心病介入术后支架内再狭窄、降低远期主要心血管事件的主要手段。
Medicine treatment plays key role in reducing the rate of restenosis and major adverse cardiac events.
目的血管腔内支架成形术目前已被证明是治疗外周动脉硬化闭塞症（PAOD）的有效方法，然而术后出现的再狭窄影响了支架成形术的疗效。
Objective:It is proved that Percutaneous Transluminal Angioplasty and Stenting is a effective treatment of PAOD, but its benefits is seriosly limited by local thrombotic occlusion and restenosis.
目的：探讨糖尿病合并冠心病老年患者支架植入术后三联抗血小板治疗对预防支架内血栓形成和再狭窄的有效性及安全性。
Objective: To investigate the safety and efficacy of triple antiplatelet therapy in aged patients with diabetes mellitus combined with coronary heart disease after percutaneous coronary intervention.
目的：探讨糖尿病合并冠心病老年患者支架植入术后三联抗血小板治疗对预防支架内血栓形成和再狭窄的有效性及安全性。
Objective: To investigate the safety and efficacy of triple antiplatelet therapy in aged patients with diabetes mellitus combined with coronary heart disease after percutaneous coronary intervention.
应用推荐